• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PFIZER CONSUMER HEALTH CARE THERMACARE LOWER BACK & HIP; DISPOSABLE PACK, HOT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PFIZER CONSUMER HEALTH CARE THERMACARE LOWER BACK & HIP; DISPOSABLE PACK, HOT Back to Search Results
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Contusion (1787); Scarring (2061); Discomfort (2330); Burn, Thermal (2530)
Event Date 08/01/2014
Event Type  Injury  
Event Description
Marks/permanent scar on back [scar].Burns on back/suffered burns [thermal burn].Bruises/marks on back [contusion].Soreness [discomfort].Case description: this is a spontaneous report from a contactable consumer or other non-hcp.A (b)(6) male patient of unspecified ethnicity started using (b)(6) heatwrap ((b)(6) lower back and hip) since an unknown date at an unknown frequency for an unknown indication.Relevant medical history and concomitant medication were unknown.It was reported that since an unknown date the patient experienced burns, soreness and marks/bruises on his back while using the heatwrap.The reporter stated they followed the instruction on the box.Relevant laboratory data was unknown.The last action taken with the heatwrap was unknown.Therapeutic measures taken in response to the reported event included unspecified treatment.Clinical outcome of the reported events was unknown at the time of report.Additional information has been requested and will be provided as it becomes available.Follow-up ((b)(6) 2014): follow-up attempts completed.No further information expected.Follow-up ((b)(6) 2015): new information received from contactable consumer includes: therapeutic measures taken and additional event of discomfort.Follow-up ((b)(6) 2015): follow-up attempts completed.No further information expected.Follow-up ((b)(6) 2015): this contactable consumer reported by way of consumer questionnaire.This (b)(6), male patient started to use (b)(6) heatwrap ((b)(6) lower back and hip) one patch once daily for 2-3 hours at most for approximately 3 days in (b)(6) 2014 for lower back pain.He applied the product directly to skin and checked frequently during usage.On third day of his use in (b)(6) 2014, he suffered burns, soreness, breaking of the skin, bruises on back and burned his back and left marks/permanent scar on back.It was reported that he still experiencing marks/permanent scar on back.He discontinued the usage of product in (b)(6) 2014.On an unknown date, he received unknown treatment for burns.On an unknown date, he was hospitalized for marks/permanent scar on back.As of (b)(6) 2015, the clinical outcome of the event marks/permanent scar on back was not recovered.
 
Event Description
Event verbatim [preferred term].Marks/permanent scar on back [scar], burns on back/suffered burns [thermal burn], bruises/marks on back [contusion], soreness [discomfort].Narrative: this is a spontaneous report from a contactable consumer or other non-healthcare professional.A 13 year old male patient started using thermacare heatwrap (thermacare lower back & hip) at one patch once daily for 2-3 hours at most for approximately 3 days in (b)(6) 2014 for lower back pain.Relevant medical history and concomitant medication were unknown.It was reported that since an unknown date the patient experienced burns, soreness and marks/bruises on his back while using the heatwrap.He applied the product directly to skin and checked frequently during usage.On third day of his use in (b)(6) 2014, he suffered burns, soreness, breaking of the skin, bruises on back and burned his back and left marks/permanent scar on back.The reporter stated they followed the instructions on the box.Relevant laboratory data was unknown.On an unknown date, he was hospitalized for marks/permanent scar on back.The last action taken with thermacare heatwrap was discontinued in (b)(6) 2014.Therapeutic measures taken in response to the reported event included unspecified treatment.It was reported that he still experiencing (not recovered) from marks/permanent scar on back.Clinical outcome of all other events was unknown at the time of report.Product investigation results were as follows: other trend assessment & rationale: an evaluation was made by searching for possible trend for this subclass.The following complaint intake, triage and investigation (citi) search was performed.Scope: date contacted: (b)(6) 2011 through (b)(6) 2014.Manufacturing site: pfizer albany/complaint class: external cause investigation/ complaint sub class: adverse event safety request for investigation.The citi search returned a total 37 complaints for the lower back and hip (lbh) products during this time period for the class/subclass adverse event safety request for investigation.None of the complaints were confirmed to have a manufacturing process root cause for a complaint of adverse event safety request for investigation.The subclass shows a seasonality increase in complaints for (b)(6) 2012.A citi complaint trend search was conducted for the subclass adverse event safety request for investigation for lbh products.The data did not show an increase over time (36 months).There is not a trend identified for the subclass adverse event safety request for investigation for lbh products.There is no further action required.Conclusion: the root cause category is non-assignable (complaint not confirmed as a quality defect).There was limited device specific information provided, no batch number or return sample was available for evaluation.Without a batch reference number and/or return sample a manufacturing and technical evaluation cannot be completed for the wrap involved in this case.There is not a product quality related trend identified for the subclass adverse event safety request for investigation.The manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.Reasonably suggest device malfunction: no.Severity of harm: n/a.Site sample status was not received.Follow-up (12oct2014): follow-up attempts completed.No further information expected.Follow-up (09feb2015): new information received from contactable consumer includes: therapeutic measures taken and additional event of discomfort.Follow-up (08apr015): follow-up attempts completed.No further information expected.Follow-up (22may2015): new information from a contactable consumer reported by way of consumer questionnaire includes: patient information (updated age), product information (added doe, units, frequency, start and stop date), reaction data, and hospitalization.Follow-up (17apr2020): new information received from a product quality complaint group includes: product investigation results.Follow-up attempts completed.No further information expected.
 
Manufacturer Narrative
Other trend assessment & rationale: an evaluation was made by searching for possible trend for this subclass.The following complaint intake, triage and investigation (citi) search was performed.Scope: date contacted: (b)(6) 2011 through (b)(6) 2014.Manufacturing site: pfizer albany/complaint class: external cause investigation/ complaint sub class: adverse event safety request for investigation.The citi search returned a total 37 complaints for the lower back and hip (lbh) products during this time period for the class/subclass adverse event safety request for investigation.None of the complaints were confirmed to have a manufacturing process root cause for a complaint of adverse event safety request for investigation.The subclass shows a seasonality increase in complaints for (b)(6) 2012.A citi complaint trend search was conducted for the subclass adverse event safety request for investigation for lbh products.The data did not show an increase over time (36 months).There is not a trend identified for the subclass adverse event safety request for investigation for lbh products.There is no further action required.Conclusion: the root cause category is non-assignable (complaint not confirmed as a quality defect).There was limited device specific information provided, no batch number or return sample was available for evaluation.Without a batch reference number and/or return sample a manufacturing and technical evaluation cannot be completed for the wrap involved in this case.There is not a product quality related trend identified for the subclass adverse event safety request for investigation.The manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.Reasonably suggest device malfunction: no.Severity of harm: n/a.Site sample status was not received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMACARE LOWER BACK & HIP
Type of Device
DISPOSABLE PACK, HOT
Manufacturer (Section D)
PFIZER CONSUMER HEALTH CARE
1231 wyandotte drive
albany GA 31705
MDR Report Key4814971
MDR Text Key5895711
Report Number1066015-2015-00061
Device Sequence Number1
Product Code IMD
Combination Product (y/n)N
PMA/PMN Number
K953442
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Type of Report Initial,Followup
Report Date 08/19/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Initial Date Manufacturer Received 05/22/2015
Initial Date FDA Received06/01/2015
Supplement Dates Manufacturer Received05/22/2015
Supplement Dates FDA Received04/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age13 YR
-
-